Zdrowie i gospodarka · 07/08/2002
FDA Releases Revised Draft Guidance on Modified-Release Potassium Chloride Dosage Forms
The FDA has made a revised draft guidance document available for industry, outlining recommendations for designing bioequivalence studies for modified-release potassium chloride dosage forms, particularly for abbreviated new drug applications (ANDAs).
Source: Federal Register — Food and Drug AdministrationOpen original release →